Hanne Ellekjaer
Overview
Explore the profile of Hanne Ellekjaer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
736
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Giri S, Tronvik E, Dalen H, Ellekjaer H, Loennechen J, Olsen A, et al.
Cephalalgia
. 2024 May;
44(5):3331024241254517.
PMID: 38808530
Background: Data from some population-based studies have indicated an increased risk of atrial fibrillation (AF) among patients with migraine, particularly among individuals with migraine with aura. The present study aimed...
2.
Gemes K, Malmo V, Strand L, Ellekjaer H, Loennechen J, Janszky I, et al.
J Sleep Res
. 2024 Jan;
33(5):e14156.
PMID: 38284226
Studies on the effect of insomnia on atrial fibrillation risk in the general population are limited, therefore we investigated the association between insomnia and the risk of atrial fibrillation in...
3.
Anjum M, Ariansen I, Hjellvik V, Selmer R, Kjerpeseth L, Skovlund E, et al.
Eur Heart J
. 2023 Nov;
45(1):57-66.
PMID: 37995254
Background And Aims: The benefit of oral anticoagulant (OAC) therapy in atrial fibrillation (AF) and intermediate stroke risk is debated. In a nationwide Norwegian cohort with a non-sex CHA2DS2-VASc risk...
4.
Aakeroy R, Gynnild M, Lofblad L, Dyrkorn R, Ellekjaer H, Lydersen S, et al.
Basic Clin Pharmacol Toxicol
. 2023 Oct;
134(1):175-185.
PMID: 37845026
No therapeutic ranges linking drug concentrations of apixaban and rivaroxaban to clinical outcomes have been defined. We investigated whether direct oral anticoagulant (DOAC) concentrations among patients admitted to hospital with...
5.
Askim T, Hokstad A, Bergh E, Dohl O, Ellekjaer H, Ihle-Hansen H, et al.
BMJ Open
. 2023 May;
13(5):e069656.
PMID: 37164457
Introduction: Multimodal interventions have emerged as new approaches to provide more targeted intervention to reduce functional decline after stroke. Still, the evidence is contradictory. The main objective of the Life...
6.
Sandvig H, Aam S, Alme K, Askim T, Beyer M, Ellekjaer H, et al.
Stroke
. 2023 Apr;
54(5):1303-1311.
PMID: 37026459
Background: Inflammation is proposed to be involved in the pathogenesis of poststroke cognitive impairment. The aim of this study was to investigate associations between concentrations of systemic inflammatory biomarkers after...
7.
Ronning O, Carlsson M, Ihle-Hansen H, Aamodt A, Tveiten A, Eltoft A, et al.
Tidsskr Nor Laegeforen
. 2022 Oct;
142(14).
PMID: 36226425
No abstract available.
8.
Gynnild M, Hageman S, Spigset O, Lydersen S, Saltvedt I, Dorresteijn J, et al.
Open Heart
. 2022 Apr;
9(1).
PMID: 35459718
Objectives: Elevated low-density lipoprotein cholesterol (LDL-C) increases the risk of recurrent cardiovascular disease (CVD) events. We examined use of lipid-lowering therapy (LLT) following ischaemic stroke, and estimated benefits from guideline-based...
9.
Hageman S, McKay A, Ueda P, Gunn L, Jernberg T, Hagstrom E, et al.
Eur Heart J
. 2022 Feb;
43(18):1715-1727.
PMID: 35165703
Aims: The 10-year risk of recurrent atherosclerotic cardiovascular disease (ASCVD) events in patients with established ASCVD can be estimated with the Secondary Manifestations of ARTerial disease (SMART) risk score, and...
10.
Saxhaug L, Graven T, Olsen O, Kleinau J, Skjetne K, Ellekjaer H, et al.
Open Heart
. 2022 Feb;
9(1).
PMID: 35105719
Objectives: To investigate the reliability and agreement of hand-held ultrasound devices (HUDs) compared with conventional duplex ultrasound (HIGH) in examination for carotid stenosis in patients with suspected transitory ischaemic attack...